-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $704

Benzinga·07/07/2026 16:21:50
Listen to the news
RBC Capital analyst Lisa Walter maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target from $701 to $704.